This list is based on the watchlists of people on Stock Events who follow GNFTF. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Genfit S.A. operates as a biopharmaceutical enterprise, concentrating its efforts on discovering and developing both therapeutic candidates and diagnostic solutions for metabolic and liver-related ailments. Its current pipeline includes Elafibranor, which is progressing through Phase 3 clinical trials for the treatment of primary biliary cholangitis (PBC). The firm is additionally engaged in advancing the NIS4 technology, designed for the accurate diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis. Other investigational treatments comprise GNS561, currently in Phase 1b/2 trials for cholangiocarcinoma (CCA), and Nitazoxanide, undergoing Phase 1 evaluation for acute-on-chronic liver failure. Genfit has established key partnerships, notably a licensing agreement with Labcorp for the commercialization of NASHnext, a molecular diagnostic test leveraging blood samples. Furthermore, it collaborates with Genoscience Pharma on the development and market launch of the experimental CCA therapy, GNS561. Established in 1999, Genfit S.A. maintains its headquarters in Loos, France.
FAQs
What is Genfit stock price today?▼
The current price of GNFTF is $9.43 USD — it has increased by +0% in the past 24 hours. Watch Genfit stock price performance more closely on the chart.
What is Genfit stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Genfit stocks are traded under the ticker GNFTF.
What is Genfit market cap?▼
Today Genfit has the market capitalization of 472.43M
When is the next Genfit earnings date?▼
Genfit is going to release the next earnings report on April 8, 2027.
What were Genfit earnings last quarter?▼
GNFTF earnings for the last quarter are -0.23 USD per share, whereas the estimation was -0.18 USD resulting in a -25% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Genfit revenue for the last year?▼
Genfit revenue for the last year amounts to 76.95M USD.
What is Genfit net income for the last year?▼
GNFTF net income for the last year is -100.92M USD.
How many employees does Genfit have?▼
As of November 19, 2026, the company has 180 employees.
In which sector is Genfit located?▼
Genfit operates in the Health & Wellness sector.
When did Genfit complete a stock split?▼
Genfit has not had any recent stock splits.
Where is Genfit headquartered?▼
Genfit is headquartered in Loos, France.